Sodium-glucose co-transporter-2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes Post date 1 October 2024 ← Sorting out scope of practice of physician associates in the UK: the clock is ticking → HPV9 vaccination and risk of immune mediated diseases in Denmark